Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia

Journal of Biomedical Science

Volumn 21, Issue 1, 2014, Pages

  Zhao, Guangfeng ^a   Zhou, Xue ^b   Chen, Shiwen ^a   Miao, Huishuang ^b   Fan, Hongye ^b   Wang, Zhiqun ^a   Hu, Yali ^a   Hou, Yayi ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Mesenchymal stem cells; Microarray; miRNAs; Pre eclampsia

Indexed keywords

B LYMPHOCYTE RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; MICRORNA; MICRORNA 100; MICRORNA 1207; MICRORNA 136; MICRORNA 140 3P; MICRORNA 140 5P; MICRORNA 148A; MICRORNA 16; MICRORNA 221; MICRORNA 29B; MICRORNA 301A; MICRORNA 30A; MICRORNA 324 5P; MICRORNA 376A; MICRORNA 4270; MICRORNA 4324; MICRORNA 494; MICRORNA 495; MICRORNA 99A; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE 2A REGULATORY SUBUNIT B ALPHA; PROTEIN; SUPPRESSION OF CYTOKINE SIGNALING 3; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ADULT; AGING; ANGIOGENESIS; APOPTOSIS; ARTICLE; BIOINFORMATICS; CELL CYCLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; DIASTOLIC BLOOD PRESSURE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE ONTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNE RESPONSE; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; PATHOGENESIS; PHENOTYPE; PREECLAMPSIA; PREGNANCY; PROTEINURIA; REPORTER GENE; SYSTOLIC BLOOD PRESSURE; UPREGULATION; WNT SIGNALING PATHWAY; BIOSYNTHESIS; CELL CULTURE; CLINICAL TRIAL; GENE EXPRESSION REGULATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ADULT; CELL PROLIFERATION; CELLS, CULTURED; DECIDUA; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; PRE-ECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

EID: 84906931886     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/s12929-014-0081-3     Document Type: Article

References (54)

1. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. CC Zhou, YJ Zhang, RA Irani, Nat Med 2008 14 855 862 10.1038/nm.1856 18660815
2. Latest advances in understanding pre-eclampsia. CW Redman, IL Sargent, Science 2005 308 1592 1594 10.1126/science.1111726 15947178
3. The biology of preeclampsia. K Kanasaki, R Kalluri, Kidney Int 2009 76 831 837 10.1038/ki.2009.284 19657323
4. Examination of distinct fetal and maternal molecular pathways suggests a mechanism for the development of preeclampsia. DS Goldman-Wohl, S Yagel, J Reprod Immunol 2007 76 54 60 10.1016/j.jri.2007.03.012 17482678
5. Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia. A Rolfo, D Giuffrida, AM Nuzzo, PLoS One 2013 8 3 59403 10.1371/journal.pone.0059403 23527185
6. Immunology of the maternal-fetal interface. A Erlebacher, Annu Rev Immunol 2013 31 387 411 10.1146/annurev-immunol-032712-100003 23298207
7. Soluble endoglin contributes to the pathogenesis of preeclampsia. S Venkatesha, M Toporsian, C Lam, J Hanai, T Mammoto, YM Kim, Nat Med 2006 12 642 649 10.1038/nm1429 16751767
8. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. I Verlohren, H Stepan, R Dechend, Clin Sci 2012 122 43 52 10.1042/CS20110097 21929511
9. The uterine spiral arteries in human pregnancy: facts and controversies. R Pijnenborg, L Vercruysse, M Hanssens, Placenta 2006 7 939 958 10.1016/j.placenta.2005.12.006
10. Angiogenic Factors in Superimposed Preeclampsia A Longitudinal Study of Women With Chronic Hypertension During Pregnancy. EU Perni, C Sison, V Sharma, G Helseth, A Hawfield, M Suthanthiran, Hypertension 2012 59 740 746 10.1161/HYPERTENSIONAHA.111.181735 22311907
11. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. S Karahuseyinoglu, O Cinar, E Kilic, Stem Cells 2007 25 319 331 10.1634/stemcells.2006-0286 17053211
12. A novel way to isolate MSCs from umbilical cords. L Liu, X Zhao, P Li, G Zhao, Y Wang, Y Hou, Eur J Immunol 2012 42 2190 2193 10.1002/eji.201142356 22585466
13. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. P Bianco, X Cao, PS Frenette, JJ Mao, PG Robey, PJ Simmons, Nat Med 2013 19 1 35 42 10.1038/nm.3028 23296015
14. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation. MJ Crop, CC Baan, SS Korevaar, Stem Cells Dev 2010 19 1843 1853 10.1089/scd.2009.0368 20367242
15. Mesenchymal stem cells suppress B-cell terminal differentiation. S Asari, S Itakura, K Ferreri, Exp Hematol 2009 37 604 615 10.1016/j.exphem.2009.01.005 19375651
16. Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. M Giuliani, N Oudrhiri, ZM Noman, Blood 2011 118 3254 3262 10.1182/blood-2010-12-325324 21803852
17. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. GM Spaggiari, H Abdelrazik, F Becchetti, Blood 2009 113 6576 6583 10.1182/blood-2009-02-203943 19398717
18. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. Q Zhang, S Shi, Y Liu, J Immunol 2009 183 7787 7798 10.4049/jimmunol.0902318 19923445
19. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. L Sun, D Wang, J Liang, Arthritis Rheum 2010 62 2467 2475 10.1002/art.27548 20506343
20. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. L Sun, K Akiyama, H Zhang, Stem Cell 2009 27 1421 1432 10.1002/stem.68
21. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. JY Hsieh, HW Wang, SJ Chang, KH Liao, IH Lee, WS Lin, PLoS One 2013 8 8 72604 10.1371/journal.pone.0072604 23991127
22. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. AJ Cutler, V Limbani, J Girdlestone, J Immunol 2010 185 6617 6623 10.4049/jimmunol.1002239 20980628
23. Potential for mesenchymal stem cell isolation from human placenta. K Atkinson, K Chatterjee, S Barlow, Blood 2005 106 158b 158b 10.1182/blood-2004-08-3232
24. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. KE Schwab, CE Gargett, Hum Reprod 2007 22 2903 2911 10.1093/humrep/dem265 17872908
25. Cytokine expression in placentaderived mesenchymal stem cells in patients with pre-eclampsia and normal pregnancies. JH Hwang, MJ Lee, OS Seok, Cytokine 2010 49 95 101 10.1016/j.cyto.2009.08.013 19819721
26. Placental stem cell markers in preeclampsia. A Benian, H Uzun, S Aydin, Int J Gynaecol Obstet 2008 100 228 233 10.1016/j.ijgo.2007.09.023 18048043
27. MicroRNAs: genomics, biogenesis, mechanism, and function. DP Bartel, Cell 2004 116 281 297 10.1016/S0092-8674(04)00045-5 14744438
28. Pervasive roles of microRNAs in cardiovascular biology. EM Small, EN Olson, Nature 2011 469 336 342 10.1038/nature09783 21248840
29. MicroRNAs: fundamental facts and involvement in human diseases. G Di Leva, GA Calin, CM Croce, Birth Defects Res C Embryo Today 2006 78 180 189 10.1002/bdrc.20073 16847883
30. MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment. EM Heinrich, S Dimmeler, Circ Res 2012 110 1014 1022 10.1161/CIRCRESAHA.111.243394 22461365
31. The functions of microRNAs in pluripotency and reprogramming. TR Leonardo, HL Schultheisz, JF Loring, LC Laurent, Nat Cell Biol 2012 14 1114 1121 10.1038/ncb2613 23131918
32. miRNA expression profiling in formalin-fixed and paraffin-embedded placental tissue samples from pregnancies with severe preeclampsia. F Noack, J Ribbat-Idel, C Thorns, A Chiriac, R Axt-Fliedner, K Diedrich, J Perinat Med 2011 39 267 271 10.1515/jpm.2011.012 21309633
33. Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Y Hu, P Li, S Hao, L Liu, J Zhao, Y Hou, Clin Chem Lab Med 2009 47 923 929 19642860
34. Decidua parietalis-derived mesenchymal stromal cells reside in a vascular niche within the choriodecidua. NM Castrechini, P Murthi, S Qin, GD Kusuma, L Wilton, M Abumaree, S Gronthos, A Zannettino, NM Gude, SP Brennecke, B Kalionis, Reprod Sci 2012 19 12 1302 1314 10.1177/1933719112450334 22886285
35. Isolation and cellular properties of mesenchymal cells derived from the decidua of human term placenta. D Kanematsu, T Shofuda, A Yamamoto, C Ban, T Ueda, M Yamasaki, Y Kanemura, Differentiation 2011 82 2 77 88 10.1016/j.diff.2011.05.010 21684674
36. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. R Hass, C Kasper, S Böhm, R Jacobs, Cell Commun Signal 2011 9 12 10.1186/1478-811X-9-12 21569606
37. miR-16 inhibits the proliferation and angiogenesis-regulating potential of mesenchymal stem cells in severe pre-eclampsia. Y Wang, H Fan, G Zhao, D Liu, L Du, Z Wang, Y Hu, Y Hou, FEBS J 2012 279 24 4510 4524 10.1111/febs.12037 23083510
38. Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study. Y Cheng, W Liu, ST Kim, J Sun, L Lu, J Sun, SL Zheng, WB Isaacs, J Xu, Cancer Genet 2011 204 7 375 381 10.1016/j.cancergen.2011.05.002 21872824
39. Zhou C, Zhang X, Xu L, Wu T, Cui L, Xu D: Taurine promotes human mesenchymal stem cells to differentiate into osteoblast through the ERK pathway. Amino Acids 2014, [Epub ahead of print].
40. Salvianolic acid B promotes osteogenesis of human mesenchymal stem cells through activating ERK signaling pathway. D Xu, L Xu, C Zhou, WY Lee, T Wu, L Cui, G Li, Int J Biochem Cell Biol 2011 51C 1 9
41. The two stage model of preeclampsia: variations on the theme. JM Roberts, CA Hubel, Placenta 2009 30 32 S37 10.1016/j.placenta.2008.11.009 19070896
42. Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A. S Shen, H Yue, Y Li, J Qin, K Li, Y Liu, J Wang, Tumour Biol 2014 35 1 631 640 10.1007/s13277-013-1087-2 23959478
43. microRNA-29b contributes to pre-eclampsia through its effects on apoptosis, invasion and angiogenesis of trophoblast cells. P Li, W Guo, L Du, J Zhao, Y Wang, L Liu, Y Hu, Y Hou, Clin Sci (Lond) 2013 124 1 27 40 10.1042/CS20120121
44. MicroRNA-181a regulates local immune balance by inhibiting proliferation and immunosuppressive properties of mesenchymal stem cells. L Liu, Y Wang, H Fan, X Zhao, D Liu, Y Hu, AR Kidd 3rd, J Bao, Y Hou, Stem Cells 2012 30 8 1756 1770 10.1002/stem.1156 22714950
45. Angiogenic factors and preeclampsia. SE Maynard, SA Karumanchi, Semin Nephrol 2011 31 33 46 10.1016/j.semnephrol.2010.10.004 21266263
46. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. A Izzotti, GA Calin, P Arrigo, VE Steele, CM Croce, S De Flora, FASEB J 2009 23 3 806 812 10.1096/fj.08-121384 18952709
47. Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4. QB Huang, X Ma, X Zhang, SW Liu, Q Ai, TP Shi, Y Zhang, Y Gao, Y Fan, D Ni, BJ Wang, HZ Li, T Zheng, PLoS One 2013 8 6 67294 10.1371/journal.pone.0067294 23826258
48. MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. S Grundmann, FP Hans, S Kinniry, J Heinke, T Helbing, F Bluhm, JP Sluijter, I Hoefer, G Pasterkamp, C Bode, M Moser, Circulation 2011 123 9 999 1009 10.1161/CIRCULATIONAHA.110.000323 21339483
49. miR-16 targets transcriptional corepressor SMRT and modulates NF-kappaB-regulated transactivation of interleukin-8 gene. R Zhou, X Li, G Hu, AY Gong, KM Drescher, XM Chen, PLoS One 2012 7 1 30772 10.1371/journal.pone.0030772 22292036
50. MicroRNA-29 in the adaptive immune system: setting the threshold. A Liston, AS Papadopoulou, D Danso-Abeam, J Dooley, Cell Mol Life Sci 2012 69 21 3533 3541 10.1007/s00018-012-1124-0 22971773
51. MiRNA-29: a microRNA family with tumor-suppressing and immune-modulating properties. MJ Schmitt, C Margue, I Behrmann, S Kreis, Curr Mol Med 2013 13 4 572 585 10.2174/1566524011313040009 22934851
52. Low-Dose Paclitaxel Ameliorates Pulmonary Fibrosis by Suppressing TGF-β1/Smad3 Pathway via miR-140 Upregulation. C Wang, X Song, Y Li, F Han, S Gao, X Wang, S Xie, C Lv, PLoS One 2013 8 8 70725 10.1371/journal.pone.0070725 23967091
53. MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn. Y Liu, J Dong, R Mu, Y Gao, X Tan, Y Li, Z Li, G Yang, Arthritis Rheum 2013 65 6 1603 1611 10.1002/art.37912 23450709
54. MicroRNA-221-222 regulate the cell cycle in mast cells. RJ Mayoral, ME Pipkin, M Pachkov, E van Nimwegen, A Rao, S Monticelli, J Immunol 2009 182 1 433 445 10.4049/jimmunol.182.1.433 19109175